| Literature DB >> 15808820 |
Jacek J Slon-Usakiewicz1, William Ng, Jin-Rui Dai, Andrew Pasternak, Peter R Redden.
Abstract
The emergence of a relatively new technique resulting from a combination of frontal affinity chromatography coupled with MS detection (FAC-MS) has extended the capabilities of MS in drug discovery and development. Its application in a broad range of biological systems, together with its label-free operation, relatively high throughput, ability to rank ligands and determine Kd, makes FAC-MS a universal tool enabling convenient and efficient screening in the identification of new potential drug leads. Here we will highlight FAC-MS screening studies and discuss where it can be applied in evaluating multiple protein-binding sites, protein-protein interactions and inactive proteins, and also in determining selectivity.Mesh:
Substances:
Year: 2005 PMID: 15808820 DOI: 10.1016/S1359-6446(04)03360-4
Source DB: PubMed Journal: Drug Discov Today ISSN: 1359-6446 Impact factor: 7.851